Abstract:Background & aims: Temporal oscillations in intestinal nutrient processing and absorption are coordinated by the local clock, which leads to the hypothesis that the intestinal clock has major impacts on shaping peripheral rhythms via diurnal nutritional signals. Here, we investigate the role of the intestinal clock in controlling liver rhythmicity and metabolism. Methods: Transcriptomic analysis, metabolomics, metabolic assays, histology, quantitative (q)PCR, and immunoblotting were performed with Bmal1-intestine-specific knockout (iKO), Rev-erba-iKO, and control mice. Results: Bmal1 iKO caused large-scale reprogramming of the rhythmic transcriptome of mouse liver with a limited effect on its clock. In the absence of intestinal Bmal1, the liver clock was resistant to entrainment by inverted feeding and a high-fat diet. Importantly, Bmal1 iKO remodelled diurnal hepatic metabolism by shifting to gluconeogenesis from lipogenesis during the dark phase, leading to elevated glucose production (hyperglycaemia) and insulin insensitivity. Conversely, Rev-erba iKO caused a diversion to lipogenesis from gluconeogenesis during the light phase, resulting in enhanced lipogenesis and an increased susceptibility to alcohol-related liver injury. These temporal diversions were attributed to disruption of hepatic SREBP-1c rhythmicity, which was maintained via gut-derived polyunsaturated fatty acids produced by intestinal FADS1/2 under the control of a local clock. Conclusions: Our findings establish a pivotal role for the intestinal clock in dictating liver rhythmicity and diurnal metabolism, and suggest targeting intestinal rhythms as a new avenue for improving metabolic health. Impact and implications: Our findings establish the centrality of the intestinal clock among peripheral tissue clocks, and associate liver-related pathologies with its malfunction. Clock modifiers in the intestine are shown to modulate liver metabolism with improved metabolic parameters. Such knowledge will help clinicians improve the diagnosis and treatment of metabolic diseases by incorporating intestinal circadian factors.

CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1.

CLOCK and BMAL1 Regulate Muscle Insulin Sensitivity Via SIRT1 in Male Mice

Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of M6a Mrna Methylation.

Insulin Post-Transcriptionally Modulates Bmal1 Protein to Affect the Hepatic Circadian Clock

CLOCK and BMAL 1 Regulate Muscle Insulin Sensitivity via SIRT 1 in Male Mice

Palmitate Inhibits SIRT1-Dependent BMAL1/CLOCK Interaction and Disrupts Circadian Gene Oscillations in Hepatocytes

Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein*

Reprogramming of rhythmic liver metabolism by intestinal clock

Hepatic Circadian-Clock System Altered by Insulin Resistance, Diabetes and Insulin Sensitizer in Mice

SIRT7 couples light-driven body temperature cues to hepatic circadian phase coherence and gluconeogenesis

Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness

Rhythmic expression of miR‐27b‐3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver

Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice

Switch/Sucrose Nonfermentable (Swi/Snf) Complex Subunit Baf60a Integrates Hepatic Circadian Clock And Energy Metabolism

Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein

[Internal Circadian Clock and Liver Metabolism].

RBP4 Functions As a Hepatokine in the Regulation of Glucose Metabolism by the Circadian Clock in Mice

The Diurnal Rhythm of Insulin Receptor Substrate-1 (IRS-1) and Kir4.1 in Diabetes: Implications for a Clock Gene Bmal1

BMAL1 Deletion Protects Against Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet

Liver and muscle circadian clocks cooperate to support glucose tolerance in mice

Metabolic Profile and Lipid Metabolism Phenotype in Mice with Conditional Deletion of Hepatic BMAL1